BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang S, Meng Q, Xie Q, Zhang M. Effect and mechanism of resveratrol on drug resistance in human bladder cancer cells. Mol Med Rep 2017;15:1179-87. [PMID: 28098863 DOI: 10.3892/mmr.2017.6111] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu S, Xiong R, Huang S, Zhou D, Saimaiti A, Zhao C, Shang A, Zhang Y, Gan R, Li H. Effects and mechanisms of resveratrol for prevention and management of cancers: An updated review. Critical Reviews in Food Science and Nutrition. [DOI: 10.1080/10408398.2022.2101428] [Reference Citation Analysis]
2 Chang YY, Lin HJ, Hsiao LC, Lin YF, Chang CS, Liu DZ. Reduction of breast tumor drug resistance by 2,3,5,4'-tetrahydroxystilbene for exhibition synergic chemotherapeutic effect. PLoS One 2021;16:e0260533. [PMID: 34874967 DOI: 10.1371/journal.pone.0260533] [Reference Citation Analysis]
3 Zhu Y, Piao C, Zhang Z, Jiang Y, Kong C. The potential role of c-MYC and polyamine metabolism in multiple drug resistance in bladder cancer investigated by metabonomics. Genomics 2021;114:125-37. [PMID: 34843906 DOI: 10.1016/j.ygeno.2021.11.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Almeida TC, Silva GND. Resveratrol effects in bladder cancer: A mini review. Genet Mol Biol 2021;44:e20200371. [PMID: 33749701 DOI: 10.1590/1678-4685-GMB-2020-0371] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chestnut C, Subramaniam D, Dandawate P, Padhye S, Taylor J, Weir S, Anant S. Targeting Major Signaling Pathways of Bladder Cancer with Phytochemicals: A Review. Nutrition and Cancer. [DOI: 10.1080/01635581.2020.1856895] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
6 Khan K, Quispe C, Javed Z, Iqbal MJ, Sadia H, Raza S, Irshad A, Salehi B, Reiner Ž, Sharifi-Rad J. Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K/Akt/mTOR pathway: go four better to treat bladder cancer. Cancer Cell Int 2020;20:560. [PMID: 33292283 DOI: 10.1186/s12935-020-01660-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
7 Piwowarczyk L, Stawny M, Mlynarczyk DT, Muszalska-Kolos I, Goslinski T, Jelińska A. Role of Curcumin and (-)-Epigallocatechin-3-O-Gallate in Bladder Cancer Treatment: A Review. Cancers (Basel) 2020;12:E1801. [PMID: 32635637 DOI: 10.3390/cancers12071801] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
8 Sui X, Zhang C, Jiang Y, Zhou J, Xu C, Tang F, Chen B, Xu H, Wang S, Wang X. Resveratrol activates DNA damage response through inhibition of polo-like kinase 1 (PLK1) in natural killer/T cell lymphoma. Ann Transl Med 2020;8:688. [PMID: 32617308 DOI: 10.21037/atm-19-4324] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Zhang L, Zhao G, Ji S, Yuan Q, Zhou H. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142. Med Sci Monit 2020;26:e921594. [PMID: 32155139 DOI: 10.12659/MSM.921594] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
10 Ma W, Ma J, Lei T, Zhao M, Zhang M. Targeting immunotherapy for bladder cancer by using anti-CD3 × CD155 bispecific antibody. J Cancer 2019;10:5153-61. [PMID: 31602268 DOI: 10.7150/jca.29937] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
11 Li B, Xie D, Zhang H. Long non-coding RNA GHET1 contributes to chemotherapeutic resistance to Gemcitabine in bladder cancer. Cancer Chemother Pharmacol 2019;84:187-94. [PMID: 31115606 DOI: 10.1007/s00280-019-03873-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
12 Jiang X, Lei T, Zhang M. Expression and Functions of Formyl Peptide Receptor 1 in Drug-Resistant Bladder Cancer. Technol Cancer Res Treat 2018;17:1533034618769413. [PMID: 29665744 DOI: 10.1177/1533034618769413] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
13 Wu J, Li W, Ning J, Yu W, Rao T, Cheng F. Long noncoding RNA UCA1 targets miR-582-5p and contributes to the progression and drug resistance of bladder cancer cells through ATG7-mediated autophagy inhibition. Onco Targets Ther 2019;12:495-508. [PMID: 30666128 DOI: 10.2147/OTT.S183940] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 13.0] [Reference Citation Analysis]
14 Moon JY, Manh Hung LV, Unno T, Cho SK. Nobiletin Enhances Chemosensitivity to Adriamycin through Modulation of the Akt/GSK3β/β⁻Catenin/MYCN/MRP1 Signaling Pathway in A549 Human Non-Small-Cell Lung Cancer Cells. Nutrients 2018;10:E1829. [PMID: 30486290 DOI: 10.3390/nu10121829] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
15 Ma W, Ma J, Ma P, Lei T, Zhao M, Zhang M. Targeting immunotherapy for bladder cancer using anti-CD3× B7-H3 bispecific antibody. Cancer Med 2018;7:5167-77. [PMID: 30253078 DOI: 10.1002/cam4.1775] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
16 Barros AS, Costa EC, Nunes AS, de Melo-Diogo D, Correia IJ. Comparative study of the therapeutic effect of Doxorubicin and Resveratrol combination on 2D and 3D (spheroids) cell culture models. Int J Pharm 2018;551:76-83. [PMID: 30217766 DOI: 10.1016/j.ijpharm.2018.09.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
17 Rauf A, Imran M, Suleria HAR, Ahmad B, Peters DG, Mubarak MS. A comprehensive review of the health perspectives of resveratrol. Food Funct 2017;8:4284-305. [PMID: 29044265 DOI: 10.1039/c7fo01300k] [Cited by in Crossref: 135] [Cited by in F6Publishing: 160] [Article Influence: 33.8] [Reference Citation Analysis]
18 Wieczorek E, Reszka E. mRNA, microRNA and lncRNA as novel bladder tumor markers. Clin Chim Acta 2018;477:141-53. [PMID: 29224950 DOI: 10.1016/j.cca.2017.12.009] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 7.4] [Reference Citation Analysis]
19 Jiang Z, Chen K, Cheng L, Yan B, Qian W, Cao J, Li J, Wu E, Ma Q, Yang W. Resveratrol and cancer treatment: updates. Ann N Y Acad Sci 2017;1403:59-69. [PMID: 28945938 DOI: 10.1111/nyas.13466] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 11.8] [Reference Citation Analysis]
20 Oksay T, Yunusoğlu S, Calapoğlu M, Aydın Candan I, Onaran İ, Ergün O, Özorak A. Protective impact of resveratrol in experimental rat model of hyperoxaluria. Int Urol Nephrol 2017;49:769-75. [PMID: 28185107 DOI: 10.1007/s11255-017-1534-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Khakinezhad Tehrani F, Ranji N, Kouhkan F, Hosseinzadeh S. Apoptosis induction and proliferation inhibition by silibinin encapsulated in nanoparticles in MIA PaCa-2 cancer cells and deregulation of some miRNAs. Iran J Basic Med Sci 2020;23:469-82. [PMID: 32489562 DOI: 10.22038/ijbms.2020.39427.9349] [Cited by in F6Publishing: 2] [Reference Citation Analysis]